| Target Price | $108.63 |
| Price | $74.78 |
| Potential | 45.27% |
| Number of Estimates | 28 |
| 28 Analysts have issued a price target Microchip Technology 2027 . The average Microchip Technology target price is $108.63. This is 45.27% higher than the current stock price. The highest price target is $141.75 89.56% , the lowest is $82.42 10.21% . | |
| A rating was issued by 33 analysts: 26 Analysts recommend Microchip Technology to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Microchip Technology stock has an average upside potential 2027 of 45.27% . Most analysts recommend the Microchip Technology stock at Purchase. |
29 Analysts have issued a sales forecast Microchip Technology 2027 . The average Microchip Technology sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Microchip Technology EBITDA forecast 2027. The average Microchip Technology EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
29 Microchip Technology Analysts have issued a net profit forecast 2027. The average Microchip Technology net profit estimate is
This results in the following potential growth metrics and future Net Margins:
29 Analysts have issued a Microchip Technology forecast for earnings per share. The average Microchip Technology EPS is
This results in the following potential growth metrics and future valuations:
Microchip Technology...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BMO Capital |
Outperform
➜
Outperform
|
Initiated | Aug 21 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Aug 17 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Aug 07 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Aug 07 2026 |
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | Aug 07 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Aug 07 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Aug 03 2026 |
| Analyst Rating | Date |
|---|---|
|
Initiated
BMO Capital:
Outperform
➜
Outperform
|
Aug 21 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Aug 17 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Aug 07 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Aug 07 2026 |
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Aug 07 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Aug 07 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Aug 03 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


